In late March, Facebook’s former CFO Gideon Yu had quit.  The rumor about why Yu left was that he was not getting along with Facebook co-founder Mark Zuckerberg.  An internal memo went around that Facebook was looking for a CFO that has more experience with a public company.

This is where former Genentech CFO David Ebersman comes in.  Genetech is a biotech company that was bought out by Swiss company Hoffman-La Roche for $46.8 billion on March 26, 2009.  Genentech is also an investor in 23andMe, a genetics company that was started by Google co-founder Sergey Brin’s wife.  Ebersman worked at Genentech for 15 years, but Hoffman already had a CFO making his job much less important.

Below is the full press release from Facebook that AllThingsD was able to get their hands on:

(more…)